common.study.topics.clinical

Prevention of Postpartum Hemorrhage with TXA

common.study.values.description

Prevention of Postpartum Hemorrhage With TXA

Hemorrhage remains the leading cause of maternal death worldwide. Tranexamic acid has been shown to reduce rates of hemorrhage when given prophylactically prior to cesarean delivery. It has also been shown to be an effective treatment in response to hemorrhage after a vaginal delivery. The aim of this study is to assess the impact of TXA on hemorrhage rates when given prophylactically prior to all deliveries.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Tranexamic Acid 1000 mg/10ml normal saline infusion

Infusion of Tranexamic Acid (Cyklokapron) to all consented women with the delivery of the anterior shoulder of the infant

participant.views.study.view.additional

participant.views.study.view.scientific-title

Prevention of Postpartum Hemorrhage With Tranexamic Acid (TXA)

common.study.values.clinical-trial-id

NCT03326596

participant.views.study.view.id

1aKpzb